Immortalization of SV40-Transformed Human Cells
Immortalization of SV40-Transformed Human Cells
批准号:
7274175
负责人:
HARVEY L OZER
金额:
$36.76万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-12-01 至 2009-08-31
关键词:
6q27AcuteAntibodiesApoptoticBiological AssayCandidate Disease GeneCell AgingCell DeathCell LineCell ProliferationCell fusionCellsChromosome TransferChromosomes, Human, Pair 6CodeCytogeneticsDNADNA SequenceDNA-Mediated Gene TransferDatabasesDeoxycytidineDiploidyFibroblastsFrequenciesGene ExpressionGene SilencingGenesGenomicsGoalsGrowthHaploidyHistone DeacetylationHumanHuman Cell LineLigandsLocalizedLongevityLoss of HeterozygosityMediatingMessenger RNAMethylationModelingMolecular GeneticsMutagenesisMutationOncogenesOpen Reading FramesPatternProcessProtein OverexpressionRNA InterferenceReceptor SignalingReportingReverse Transcriptase Polymerase Chain ReactionRoleSeriesSignal PathwaySimian virus 40Small Interfering RNASpheroplastsSystemTestingTetanus Helper PeptideTumor Suppressor GenesTumor Suppressor ProteinsTumor-Suppressor Gene InactivationUpper armViral Tumor AntigensYeastsbasecarcinogenesiscell transformationgenome databaseglycoprotein Gimmortalized cellneurofibromanotch proteinnovelresponserestorationsenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Normal human diploid fibroblasts (HF) undergo replicative senescence at the end of their limited lifespan and acute senescence in response to over expression of oncogenes, suggesting senescence is a tumor suppressor mechanism. We have demonstrated that transformation of HF by replication-defective SV40 sequences results in extension of lifespan (which terminates in crisis as apoptotic cell death) and promotes continuous cell proliferation, i.e. immortalization. We have developed an experimental system involving matched sets of SV40-transformed non-immortal HF (SV/HF) and their immortal derivatives to identify cellular genes involved in these processes. We have localized a gene (termed SEN6) with features of a growth suppressor to a region at 6q27, whose inactivation is involved in the immortalization of SV/HF. A series of complementary strategies are proposed to identify SEN6. We will test which of three mechanisms shown to result in inactivation of tumor suppressor genes in humans is (are) responsible; namely, loss of heterozygosity and mutation, haploinsufficiency, and/or gene silencing. Candidate genes for SEN6 identified using the Human Genome Database and the expression pattern of encoded mRNAs and ORF will be tested first by DNA-mediated gene transfer into non-immortal SV/HF for promotion of immortalization by small interfering RNA(s). We will initially assess the role of DLL-1, a ligand for the Notch receptor-signaling pathway, as a candidate based on recent information on the role of the Notch-1 in transformed cells and favorable experimental aspects of DLL-1 (moderate mRNA levels in SV/HF and availability of antibody to DLL-1). We have furthermore identified an SV40-transformed human cell line, which has a single copy of chromosome 6 (mono6) for direct test of the role of haploinsufficiency or as a target for mutagenesis of haploid SEN6. Alternatively, we will exploit YAC and/or BAC transfer to further localize the region encoding SEN6. Toward that goal, we have demonstrated that manipulation of the yeast host can markedly increase DNA transfer to human cells and propose to develop the approach further. Altogether these studies are expected to result in isolation of sequences encoding SEN6 and enhance our understanding of mechanisms of senescence and carcinogenesis as well as transformation/immortalization of SV/HF.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts.
在 SV40 转化的大鼠成纤维细胞中诱导 c-myc 介导的细胞凋亡。
DOI:
--
发表时间:
1996
期刊:
Oncogene.
影响因子:
--
作者:
[Lenahan,MK, Ozer,HL]
通讯作者:
Ozer,HL
Immortalization of human fibroblasts transformed by origin-defective simian virus 40.
起源缺陷型猿猴病毒 40 转化的人成纤维细胞的永生化。
DOI:
10.1128/mcb.7.8.2794-2802.1987
发表时间:
1987
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Neufeld,DS, Ripley,S, Henderson,A, Ozer,HL]
通讯作者:
Ozer,HL
Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.
p53 在泛素途径缺陷的突变细胞系中积累。
DOI:
10.1128/mcb.14.3.1997-2003.1994
发表时间:
1994
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Chowdary,DR, Dermody,JJ, Jha,KK, Ozer,HL]
通讯作者:
Ozer,HL
Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts.
视网膜母细胞瘤蛋白和猿猴病毒 40 依赖性人成纤维细胞永生化。
DOI:
10.1128/jvi.65.6.2845-2852.1991
发表时间:
1991
期刊:
Journal of virology
影响因子:
5.4
作者:
[Resnick-Silverman,L, Pang,Z, Li,G, Jha,KK, Ozer,HL]
通讯作者:
Ozer,HL
DOI:
--
发表时间:
1998
期刊:
Developments in biological standardization
影响因子:
--
作者:
[S. H. Kim;S. Banga;K. Jha;H. Ozer]
通讯作者:
S. H. Kim;S. Banga;K. Jha;H. Ozer
共 13 条
Interdisciplinary Training Program in Cancer Research
-
批准号:8471539
-
项目类别:
-
资助金额:$2.04万
-
财政年份:2010
-
负责人:HARVEY L OZER
-
依托单位:
Interdisciplinary Training Program in Cancer Research
-
批准号:8065531
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2010
-
负责人:HARVEY L OZER
-
依托单位:
Interdisciplinary Training Program in Cancer Research
-
批准号:8701009
-
项目类别:
-
资助金额:$6.57万
-
财政年份:2010
-
负责人:HARVEY L OZER
-
依托单位:
Interdisciplinary Training Program in Cancer Research
-
批准号:8260872
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2010
-
负责人:HARVEY L OZER
-
依托单位:
Interdisciplinary Training Program in Cancer Research
-
批准号:7763526
-
项目类别:
-
资助金额:$18.77万
-
财政年份:2010
-
负责人:HARVEY L OZER
-
依托单位:
GENE EXPRESSION IN SV40-TRANSFORMED HUMAN FIBROBLASTS
-
批准号:6216387
-
项目类别:
-
资助金额:$11.95万
-
财政年份:1999
-
负责人:HARVEY L OZER
-
依托单位:
GENE EXPRESSION IN SV40-TRANSFORMED HUMAN FIBROBLASTS
-
批准号:6200940
-
项目类别:
-
资助金额:$11.95万
-
财政年份:1999
-
负责人:HARVEY L OZER
-
依托单位:
GENE EXPRESSION IN SV40-TRANSFORMED HUMAN FIBROBLASTS
-
批准号:6097820
-
项目类别:
-
资助金额:$11.95万
-
财政年份:1998
-
负责人:HARVEY L OZER
-
依托单位:
GENE EXPRESSION IN SV40-TRANSFORMED HUMAN FIBROBLASTS
-
批准号:6267166
-
项目类别:
-
资助金额:$11.95万
-
财政年份:1998
-
负责人:HARVEY L OZER
-
依托单位:
GENE EXPRESSION IN SV40-TRANSFORMED HUMAN FIBROBLASTS
-
批准号:6233925
-
项目类别:
-
资助金额:$12.15万
-
财政年份:1997
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS
-
批准号:3115378
-
项目类别:
-
资助金额:$8.1万
-
财政年份:1991
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS
-
批准号:2048911
-
项目类别:
-
资助金额:$29.36万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS
-
批准号:3115386
-
项目类别:
-
资助金额:$28.06万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
Immortalization of SV40-Transformed Human Cells
-
批准号:6933094
-
项目类别:
-
资助金额:$38.76万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
Immortalization of SV40-Transformed Human Cells
-
批准号:6733496
-
项目类别:
-
资助金额:$38.76万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40 TRANSFORMED HUMAN CELLS
-
批准号:2748485
-
项目类别:
-
资助金额:$41.66万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS
-
批准号:3115384
-
项目类别:
-
资助金额:$27.8万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS
-
批准号:3115387
-
项目类别:
-
资助金额:$11.22万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
Immortalization of SV40-Transformed Human Cells
-
批准号:6804446
-
项目类别:
-
资助金额:$38.76万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
IMMORTALIZATION OF SV40 TRANSFORMED HUMAN CELLS
-
批准号:6598231
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1988
-
负责人:HARVEY L OZER
-
依托单位:
海外基金